Postural orthostatic tachycardia syndrome

Postural orthostatic tachycardia syndrome (POTS) be a condition wey be characterized by an abnormally large increase in heart rate upon sitting up anaa standing. POTS insyd adults be characterized by a heart rate increase of 30 beats per minute within ten minutes of standing up, wey be accompanied by oda symptoms. Na dis increased heart rate for occur insyd de absence of orthostatic hypotension (>20 mm Hg drop insyd systolic blood pressure) to be considered POTS. POTS be a disorder of de autonomic nervous system wey fi lead to a variety of symptoms, wey dey include lightheadedness, brain fog, blurred vision, weakness, fatigue, headaches, heart palpitations, exercise intolerance, nausea, difficulty concentrating, tremulousness (shaking), syncope (fainting), coldness, pain anaa numbness insyd de extremities, chest pain, den shortness of breath. Chaw symptoms be worsened plus postural changes, especially standing up. Dem fi treat POTS symptoms olus lifestyle changes such as increasing fluid, electrolyte, den salt intake, wearing compression stockings, slowing down postural changes, exercise, medication, den physical therapy.

De causes of POTS be varied. Insyd sam cases, e dey develop after a viral infection, surgery, trauma, autoimmune disease, anaa pregnancy. E sanso be shown to emerge insyd previously healthy patients after contracting COVID-19, insyd people plus Long COVID (post-COVID-19 condition), anaa possibly insyd rare cases after COVID-19 vaccination, though causative evidence be limited wey na further study be needed. POTS be more common among people wey dem get infected plus SARS-CoV-2 dan among those wey dem get vaccinated against COVID-19. About 30% of severely infected patients plus long COVID get POTS. Risk factors dey include a family history of de condition.

Treatment fi include:

 avoiding factors wey dey bring on symptoms,
 increasing dietary salt den water,

 small den frequent meals,
 avoidance of immobilization,
 wearing compression stockings, den
 medication.

Medications dem use fi include:

 beta blockers,
 pyridostigmine,
 midodrine,
 fludrocortisone, anaa
 Ivabradine.
Na more dan 50% of patients wey dema condition be triggered by a viral infection get better within five years. About 80% of patients get symptomatic improvement plus treatment, while 25% be so disabled wey dem be unable to work. Na a retrospective study on patients plus adolescent-onset show say five years after diagnosis, na 19% of patients get full resolution of symptoms.

Na dem estimat say 1–3 million people insyd de United States get POTS. De average age for POTS onset be 20, wey na e dey occur about five times more frequently insyd females dan insyd males.

 References 

 External links 





Category:Vascular diseases
Category:Peripheral nervous system disorders
Category:Endocrine diseases
Category:Syndromes
Category:Ailments of unknown cause
Category:Translated from MDWiki